8 results on '"Bovill E"'
Search Results
2. The role of the hole-extraction layer in determining the operational stability of a polycarbazole:fullerene bulk-heterojunction photovoltaic device.
- Author
-
Bovill, E., Scarratt, N., Griffin, J., Yi, H., Iraqi, A., Buckley, A. R., Kingsley, J. W., and Lidzey, D. G.
- Subjects
- *
CARBAZOLE , *HOLES (Electron deficiencies) , *HETEROJUNCTIONS , *FULLERENES , *PHOTOVOLTAIC cells , *COMPARATIVE studies , *FABRICATION (Manufacturing) - Abstract
We have made a comparative study of the relative operational stability of bulk-heterojunction organic photovoltaic (OPV) devices utilising different hole transport layers (HTLs). OPV devices were fabricated based on a blend of the polymer PCDTBT with the fullerene PC70BM, and incorporated the different HTL materials PEDOT:PSS, MoOx and V2O5. Following 620 h of irradiation by light from a solar simulator, we find that devices using the PEDOT:PSS HTL retained the highest efficiency, having a projected T80 lifetime of 14500 h. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
3. The fabrication of polyfluorene and polycarbazole-based photovoltaic devices using an air-stable process route.
- Author
-
Bovill, E., Yi, H., Iraqi, A., and Lidzey, D. G.
- Subjects
- *
POLYFLUORENES , *PHOTOVOLTAIC power systems , *PERFORMANCE evaluation , *FULLERENES , *ELECTRIC power conversion - Abstract
We report a comparative study based on the fabrication of polymer:fullerene photovoltaic (PV) devices incorporating carbazole, fluorene, and a PTB based co-polymer. We have explored the efficiency and performance of such devices when the active polymer:fullerene layer is deposited by spin-casting either under nitrogen or ambient conditions. We show that PV devices based on carbazole and fluorene based materials have very similar power conversion efficiencies when processed under both air and nitrogen, with other photobleaching measurements suggesting that such materials have comparatively enhanced photostability. Devices based on the PTB co-polymer, however, have reduced efficiency when processed in air. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
4. The endothelial microenvironment in the venous valvular sinus: thromboresistance trends and inter-individual variation.
- Author
-
Trotman, W., Taatjes, D., Callas, P., and Bovill, E.
- Subjects
- *
VENOUS thrombosis , *THROMBOMODULIN , *VENOUS valves , *SINUSITIS , *VON Willebrand factor , *INDIVIDUAL differences , *CONFOCAL microscopy - Abstract
The valve sinuses of the deep venous system are frequent sites of venous thrombus initiation. We previously reported that, in comparison with the non-valvular lumenal endothelium, the valve sinus endothelium had decreased expression of von Willebrand factor (vWF) and increased expression of endothelial protein C receptor (EPCR) and thrombomodulin (TM), suggesting alteration in the procoagulant/anticoagulant balance. We hypothesized that increased stasis in the deeper recesses of the venous valves would be associated with a gradient of increased thromboresistance. Expression of EPCR, TM, and vWF was analyzed via quantitative confocal immunofluorescence in residual saphenous veins collected following coronary artery bypass procedures. In agreement with our hypothesis, endothelial expression of vWF in the valve sinus decreased from the uppermost to the deepest region of the valve sinus. In contrast to our hypothesis, EPCR expression decreased from the uppermost to the deepest region of the valve sinus ( p < 0.001) and TM expression remained unchanged throughout the valve sinus. Comparison of the non-valvular lumenal endothelium with the valve sinus endothelium demonstrated significantly decreased vWF expression ( p < 0.001) in the valvular sinus consistent with our previous report; however, we did not observe statistically significant differences in EPCR or TM expression in this comparison. In addition, remarkable inter-individual variation in expression of these three proteins was also observed. These findings suggest that the genesis of these observations is more complex than predicted by our initial hypothesis, likely due, at least in part, to the complex rheology of the valvular sinus microenvironment. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
5. Antithrombotic therapy in children.
- Author
-
Monagle, Paul, Michelson, Alan D., Bovill, Edward, Andrew, Maureen, Monagle, P, Michelson, A D, Bovill, E, and Andrew, M
- Subjects
- *
ANTICOAGULANTS , *HEPARIN , *PROSTHETIC heart valves , *PLATELET aggregation inhibitors , *ENOXAPARIN , *ORAL drug administration , *THERAPEUTICS ,THERAPEUTIC use of fibrinolytic agents - Abstract
Examines the differences between the interaction of antithrombotic agents with the hemostatic system of the young and adults. Side effects of antithrombotic agents in children; Potential advantages of low-molecular-weight heparin over for children; Thromboembolic and hemorrhagic complications of mechanical prosthetic heart valves with no antithrombotic therapy.
- Published
- 2001
- Full Text
- View/download PDF
6. Stroke risk in an elderly population with atrial fibrillation.
- Author
-
Feinberg, William M., Kronmal, Richard A., Newman, Anne B., Kraut, Michael A., Bovill, Edwin G., Cooper, Lawton, Hart, Robert G., Hart, Feinberg, W M, Kronmal, R A, Newman, A B, Kraut, M A, Bovill, E G, Cooper, L, and Hart, R G
- Subjects
- *
CEREBROVASCULAR disease risk factors , *ATRIAL fibrillation , *CEREBROVASCULAR disease , *COMPARATIVE studies , *LONGITUDINAL method , *RESEARCH methodology , *MEDICAL cooperation , *POISSON distribution , *RESEARCH , *EVALUATION research , *PROPORTIONAL hazards models , *DISEASE complications - Abstract
Patients with nonvalvular atrial fibrillation (AF) have an increased risk of stroke, but the absolute rate of stroke varies widely depending on coexistent vascular disease. We assessed the stroke rate and predictive value of two published schemes for stroke risk stratification in a population-derived cohort of 259 elderly people with nonvalvular AF followed for a median of 5.3 years. The rate of ischemic stroke was 2.8% per year (95% confidence interval [CI] 1.9, 3.9). Thirty-one percent were predicted to be at low risk, and their stroke rate was 1.7% per year (95% CI 0.6, 3.8). Many people with AF in this population-derived cohort had relatively low rates of stroke. Further studies to reliably stratify stroke risk in patients with AF are needed. [ABSTRACT FROM AUTHOR]
- Published
- 1999
- Full Text
- View/download PDF
7. Oral anticoagulation in patients with atrial fibrillation: adherence with guidelines in an elderly cohort.
- Author
-
White, Richard H., McBurnie, Mary Ann, White, R H, McBurnie, M A, Manolio, T, Furberg, C D, Gardin, J M, Kittner, S J, Bovill, E, and Knepper, L
- Subjects
- *
PATIENT compliance , *ANTICOAGULANTS , *HEALTH of older people , *ATRIAL fibrillation , *PATIENTS - Abstract
Purpose: To determine adherence with practice guidelines in a population-based cohort of elderly persons aged 70 years or older with atrial fibrillation.Subjects and Methods: This was a cross-sectional analysis of a subgroup of participants in the Cardiovascular Health Study, a prospective observational study involving four communities in the United States. Subjects were participants with atrial fibrillation on electrocardiogram at one or more yearly examinations from 1993 to 1995. The outcome measure was self-reported use of warfarin in 1995.Results: In 1995, 172 (4.1%) participants had atrial fibrillation together with information regarding warfarin use and no preexisting indication for its use. Warfarin was used by 63 (37%) of these participants. Of the 109 participants not reporting warfarin use, 92 (84%) had at least one of the clinical risk factors (aside from age) associated with stroke in patients with atrial fibrillation. Among participants not taking warfarin, 47% were taking aspirin. Several characteristics were independently associated with warfarin use, including age [odds ratio (OR) = 0.6 per 5-year increment, 95% CI 0.5-0.9], a modified mini-mental examination score <85 points [OR = 0.3, 95% confidence interval (CI) 0.1-0.9], and among patients without prior stroke, female sex (OR = 0.5, 95% CI 0.2-1.0).Conclusions: Despite widely publicized practice guidelines to treat patients who have atrial fibrillation with warfarin, most participants who had atrial fibrillation were at high risk for stroke but were not treated with warfarin. More studies are needed to determine why elderly patients with atrial fibrillation are not being treated with warfarin. [ABSTRACT FROM AUTHOR]- Published
- 1999
- Full Text
- View/download PDF
8. Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial.
- Author
-
Bovill, Edwin G., Terrin, Michael I., Stump, David C., Berke, Andrew D., Frederick, Margaret, Collen, Desire, Feit, Frederick, Gore, Joel M., Hillis, J. David, Lambrew, Costas T., Leiboff, Roy, Mann, Kenneth G., Markis, John F., Fratt, Craig M., Sharkey, Scou W., Sopko, George, Tracy, Russell P., Chesebro, James H., Bovill, E G, and Terrin, M L
- Subjects
- *
HEMOSTATICS , *PLASMINOGEN activators , *FIBRINOLYTIC agents , *ASPIRIN , *CLINICAL trials , *COMPARATIVE studies , *CORONARY artery bypass , *DRUG administration , *DOSE-effect relationship in pharmacology , *CLINICAL drug trials , *FIBRINOGEN , *HEMORRHAGE , *HEPARIN , *RESEARCH methodology , *MEDICAL cooperation , *METOPROLOL , *MYOCARDIAL infarction , *RECOMBINANT proteins , *RESEARCH , *RESEARCH funding , *STATISTICS , *THROMBOLYTIC therapy , *TISSUE plasminogen activator , *EVALUATION research , *RANDOMIZED controlled trials , *FIBRIN fibrinogen degradation products , *PHARMACODYNAMICS - Abstract
Objectives: To assess the effects of invasive procedures, hemostatic and clinical variables, the timing of beta-blocker therapy, and the doses of recombinant plasminogen activator (rt-PA) on hemorrhagic events.Design: A multicenter, randomized, controlled trial.Setting: Hospitals participating in the Thrombolysis in Myocardial Infarction, Phase II trial (TIMI II).Interventions: Patients received rt-PA, heparin, and aspirin. The total dose of rt-PA was 150 mg for the first 520 patients and 100 mg for the remaining 2819 patients. Patients were randomly assigned to an invasive strategy (coronary arteriography with percutaneous angioplasty [if feasible] done routinely 18 to 48 hours after the start of thrombolytic therapy) or to a conservative strategy (coronary arteriography done for recurrent spontaneous or exercise-induced ischemia). Eligible patients were also randomly assigned to either immediate intravenous or deferred beta-blocker therapy.Measurements: Patients were monitored for hemorrhagic events during hospitalization.Main Results: In patients on the 100-mg rt-PA regimen, major and minor hemorrhagic events were more common among those assigned to the invasive than among those assigned to the conservative strategy (18.5% versus 12.8%, P less than 0.001). Major or minor hemorrhagic events were associated with the extent of fibrinogen breakdown, peak rt-PA levels, thrombocytopenia, prolongation of the activated partial thromboplastin time (APTT) to more than 90 seconds, weight of 70 kg or less, female gender, and physical signs of cardiac decompensation. Immediate intravenous beta-blocker therapy had no important effect on hemorrhagic events when compared with delayed beta-blocker therapy. Intracranial hemorrhages were more frequent among patients treated with the 150-mg rt-PA dose than with the 100-mg rt-PA dose (2.1% versus 0.5%, P less than 0.001). The extent of the plasmin-mediated hemostatic defect was also greater in patients receiving the 150-mg dose.Conclusions: Increased morbidity due to hemorrhagic complications is associated with an invasive management strategy in patients with acute myocardial infarction. Our findings show the complex interaction of several factors in the occurrence of hemorrhagic events during thrombolytic therapy. [ABSTRACT FROM AUTHOR]- Published
- 1991
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.